UCB Inc. v. Sandoz Inc.

1:13-cv-01216

Overview

Case Number 1:13-cv-01216

Filing Date 2013-07-10

Status Terminated

Termination Date 2015-02-26

Court District Court, D. Delaware (ded)

Presiding Judge Leonard P. Stark

Nature of Suit 830 Patent

Jurisdiction Type Federal Question

Cause of Action 35:271 Patent Infringement

Jury Demand None

Parties

Sandoz Inc.

0 Attorneys Listed

No attorneys available

UCB Inc.

0 Attorneys Listed

No attorneys available

District Court, D. Delaware (ded)

Presiding Judge

Leonard P. Stark

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Docket Entries

UCB Inc. v. Sandoz Inc.

Overview

Parties

Defendant

Sandoz Inc. Follow

Represented By

Plaintiff

UCB Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 07/11/2013)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/14/2013. Date of Expiration of Patent: 03/17/2022.Thirty Month Stay Deadline: 12/14/2015. (dmp, ) (Entered: 07/11/2013)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 38,551;. (dmp, ) (Entered: 07/11/2013)

Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 14, 2013. Date of Expiration of Patent: March 17, 2022.Thirty Month Stay Deadline: 4/28/2016. (Noreika, Maryellen) (Entered: 08/02/2013)

STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to September 9, 2013 - filed by Harris FRC Corporation, Research Corporation Technologies Inc., Sandoz Inc., UCB Inc., UCB Pharma GmbH. (Phillips, John) (Entered: 08/16/2013)

ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH by Sandoz Inc..(Phillips, John) (Entered: 09/09/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Sandoz Inc. identifying Corporate Parent Novartis AG for Sandoz Inc... (Phillips, John) (Entered: 09/09/2013)

ANSWER to 9 Answer to Complaint, Counterclaim by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH.(Noreika, Maryellen) (Entered: 09/30/2013)

PROPOSED ORDER (Scheduling) by Harris FRC Corporation, UCB Inc., UCB Pharma GmbH. (Attachments: # 1 Letter to the Honorable Leonard P. Stark)(Noreika, Maryellen) (Entered: 01/06/2014)

NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH.(Noreika, Maryellen) (Entered: 01/29/2014)

ORAL ORDER: IT IS HEREBY ORDERED that the Pretrial Conference is hereby re-scheduled for October 23, 2015 beginning at 9:00 a.m. ORDERED by Judge Leonard P. Stark on 6/23/14. Associated Cases: 1:13-cv-01206-LPS et al. (ntl) (Entered: 06/23/2014)

Track Case Updates

Sandoz Inc.

UCB Inc.